Speaker Resources

Forms

Conflict of Interest Form Speaker Waiver Form

Standards and Information

For programs delivered in Quebec, the Code of Ethics of the Conseil québécois de développment professionel continu des médecins

Presenters are responsible for ensuring that they comply with regulations made under the Copyright Act Any third party materials included in presentations must fall under educational exemptions in the Copyright Act, the fair dealing guidelines, institutional agreements, or have author permissions in place The Copyright Office is available to assist and offer helpful guidance online and can review your slide deck or presentation materials

The University of Calgary has a copyright policy, to which University Faculty members must adhere Acceptable Use of Material Projected by Copyright You must instruct participants that learning materials are for individual use only and are not to be distributed

Please ensure your presentation meets Copyright standards and review the key summary below:

  1. All images/charts must be referenced

    All images/charts must be referenced. Images that appear on multiple websites and the rights holder is unclear should be referenced as "image copyright unknown". Handouts, PDFs of the presentation, will be reviewed to ensure copyright compliance before being uploaded to the secure, password-protected website.

  2. Free stock photos and clipart

    Royalty free downloads:

  3. Summarize and cite

    Summarize and cite relevant research publications / evidence-based sources.

  4. Generic names

    Use generic names when possible. If brand names are used, the brand name should appear in parentheses after the generic name.

  5. Patient images

    Patient images may be used only if they are completely de-identified/anonymized as per HIA S.32 (1).  Images of patients from websites must be referenced and are used under the assumption that consent was given – reputable websites only should be used.

Presentation Standards

You will receive a presentation template to edit. 

Include and complete the following mandatory slides in the specified order:

  1. Slide 1 | About
    Session title, faculty name, credentials, and affiliation(s)
  2. Slide 2 | Session Learning Objectives
    Guide to Writing Learning Objectives
  3. Slide 3 | Faculty Disclosure
  4. Slide 4 | Copyright
  5. Slide 5 | AI Generated Content Disclosure
    Include if AI-generated content is used in the presentation.
    Note: It must be reviewed for equity, accuracy, and mitigation of any AI introduced bias. A human expert review must be applied to AI-assisted educational materials.
  • Summarize and cite relevant, diverse research publications/evidence-based sources.
  • References must be cited on the slide which contains the referenced information, date, etc.
  • Focus on the proposed objectives, offering relevant “Clinical Pearls” or recommendations that learners can integrate and use in practice.
  • Present content that is balanced and scientifically valid.
  • Generic names should be used in certified programs.
  • If brand names are used, the brand name should appear in parentheses after the generic name. Every drug mentioned should be referred to in a similar manner. If abbreviations of long generic drug names are required use these after the first presentation of the whole drug name.
  • Where relevant discuss both potential harms and benefits (e.g. NNT, NNH, absolute and relative risk reductions).
  • Logos and brand names outside of medications should not be used in any slides. Please read the copyright section for further details.
  • Foster a safe and inclusive learning environment by avoiding gendered, racialized, and other forms of oppressive language.
  • Contact us with any proposed title or objectives changes.
  • Share all real or apparent conflict(s) with the audience.
  • Review the session learning objectives with the audience.
  • Use interactive teaching techniques for at least 25% of the session time.
  • Include references in all teaching materials (slides or handouts).
  • Include discussion about commonly encountered barriers to practice change.
  • Do not use industry logos on the slides or handout materials.
  • Acknowledge when there is no evidence to support assertions or recommendations.
  • Provide a rationale if using only one study, or a limited selection from available studies.
  • Do not alter evidence to highlight one treatment or product.
  • High quality evidence may come from systematic reviews/meta-analyses of studies (RCTs, cohort case control studies), or single, moderate-sized, well-designed RCTs or well-designed, consistent, controlled but not randomized trials or large cohort studies.